Eli Lilly CEO: We see a path to have an Alzheimer’s disease-modifying drug

About This Source - CNBC Television

CNBC is an American pay television business news channel, which primarily carries business day coverage of U.S. and international financial markets. Following the end of the business day and on non-trading days, CNBC primarily carries financial and business-themed documentaries and reality shows.

As of February 2015, CNBC is available to approximately 93,623,000 pay television households (80.4% of households with television) in the United States.

Recent from CNBC Television:

  • Murder hornets in Washington worry experts and beekeepers
  • Doctors on digital front lines help fight India’s Covid surge
  • Second-chance hiring for ex-convicts
  • CNBC Television published this video item, entitled “Eli Lilly CEO: We see a path to have an Alzheimer’s disease-modifying drug” – below is their description.

    Eli Lilly CEO Dave Ricks how the drugmaker has worked for decades to find a way to treat Alzheimer’s disease. The company says a Phase 2 trial of donanemab reveals that the drug can slow progression of the disease by 30%.

    CNBC Television YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    Leave a Comment